The role of hydrogen in the treatment of non-small cell lung cancer Jan 30, 2024

80 patients diagnosed with NSCLC for the first time were selected and randomly divided into an observation group and a control group. Both groups were given four cycles of docetaxel + cisplatin chemotherapy, during which the observation group inhaled hydrogen from Precision Home H2 Inhaler Machine for 2 hours a day. The clinical efficacy, tumor abnormal protein (TAP), tumor markers, cytokines, and adverse reactions of the two groups of patients were compared. Results The total effective rate and disease control rate of the observation group were higher than those of the control group (P<0.05); the TAP level of the observation group after treatment was significantly lower than that of the control group (P<0.05); after treatment, CEA, CA12-5, CA15- 3. The levels of CA19-9 and CYFRA21-1 were lower than those in the control group (P <0.05); after treatment, the levels of IL-6, IL-8, and TNF-α in the observation group were lower than those in the control group (P <0.05); after treatment During the period, the incidence rates of gastrointestinal reactions, bone marrow suppression, liver and kidney damage, and rash in the observation group were lower than those in the control group (P<0.05). Conclusion Hydrogen has an auxiliary therapeutic effect on NSCLC and can reduce the adverse reactions caused by chemotherapy.

This is a clinical trial of hydrogen gas for cancer treatment. The conclusion is that hydrogen gas has an auxiliary therapeutic effect on non-small cell lung cancer and can reduce the adverse reactions of chemotherapy. Lung cancer is one of the most common malignant tumors in the world and has become the number one cause of death from malignant tumors in my country's urban population. Non-small cell lung cancer includes squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Compared with small cell carcinoma, its cancer cells grow and divide more slowly and spread and metastasize relatively late.

Small cell lung cancer accounts for about 15%-20% of bronchogenic lung cancer. When small cell lung cancer is diagnosed, about 30% of patients have tumors in the localized stage, and the rest are in the extensive stage. When the tumor spreads beyond the supraclavicular area, it is considered extensive. Expect. Compared with other types of lung cancer, small cell lung cancer has better chemotherapy and radiotherapy effects.

This study is a clinical trial in non-small cell lung cancer. Readers please pay attention to a few details, random grouping, to illustrate the objectivity of this study. The results show that there is a difference in the treatment effect between the two groups, indicating that hydrogen from H2 Generator 3000ml for Home has a promoting effect on the overall treatment effect. This cannot prove the therapeutic effect of hydrogen itself, but it can show that combined chemotherapy can increase the treatment effect. Therefore, the author concluded that adjuvant treatment is a very appropriate conclusion. There is more objective evidence for reducing the adverse effects of chemotherapy, and the conclusion is more certain.
The usage of Hydrogen from Brown’s Gas H2 Inhalation Machine in cancer treatment, from assisting other treatment methods to reducing treatment side effects, is a direction that has always been valued and adhered to in the field of hydrogen medicine. However, the clinical research evidence in this area is still insufficient. This study provides new evidence in this direction.

click here to leave a message

Leave A Message
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.